Related references
Note: Only part of the references are listed.Behavioral neuroscience of autism
Toru Takumi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder
Robyn P. Thom et al.
PSYCHOPHARMACOLOGY (2019)
Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder
M. V. Lombardo et al.
MOLECULAR PSYCHIATRY (2018)
Maternal cytomegalovirus sero-positivity and autism symptoms in children
Brooke L. Slawinski et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Modeling the Interplay Between Neurons and Astrocytes in Autism Using Human Induced Pluripotent Stem Cells
Fabiele Baldino Russo et al.
BIOLOGICAL PSYCHIATRY (2018)
Clinical trials in autism spectrum disorder: evidence, challenges and future directions
Evdokia Anagnostou
CURRENT OPINION IN NEUROLOGY (2018)
Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial
Mona Khalaj et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
Kathleen Connery et al.
TRANSLATIONAL PSYCHIATRY (2018)
A randomised, double blind, placebo-controlled trial of a fixed dose of N-acetyl cysteine in children with autistic disorder
Olivia M. Dean et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism
Bartolomeo Bertolino et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects
Alessandro Minarini et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD
Carlo Agostoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
Michael G. Aman et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)
ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis
Andrea Horvath et al.
JOURNAL OF NUTRITION (2017)
Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials
Yu-Shian Cheng et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2017)
Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis
Hai-yin Jiang et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Involvement of AMPA/kainate and GABAA receptors in topiramate neuroprotective effects against methylphenidate abuse sequels involving oxidative stress and inflammation in rat isolated hippocampus
Majid Motaghinejad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
Ali Ghaleiha et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2016)
A Prospective Open-Label Trial of Memantine Hydrochloride for the Treatment of Social Deficits in Intellectually Capable Adults With Autism Spectrum Disorder
Gagan Joshi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Neuroprotective effects of various doses of topiramate against methylphenidate-induced oxidative stress and inflammation in isolated rat amygdala: the possible role of CREB/BDNF signaling pathway
Majid Motaghinejad et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care
Kelly McGuire et al.
PEDIATRICS (2016)
Maternal immune activation: Implications for neuropsychiatric disorders
Myka L. Estes et al.
SCIENCE (2016)
A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder
Logan K. Wink et al.
MOLECULAR AUTISM (2016)
From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition
Adam M. H. Young et al.
MOLECULAR AUTISM (2016)
Acetylcysteine for treatment of autism spectrum disorder symptoms
Danielle Stutzman et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Topiramate attenuates early brain injury following subarachnoid haemorrhage in rats via duplex protection against inflammation and neuronal cell death
Yong Tian et al.
BRAIN RESEARCH (2015)
N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety
Mohammadali Nikoo et al.
CLINICAL NEUROPHARMACOLOGY (2015)
PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Atefeh Zeinoddini et al.
DEPRESSION AND ANXIETY (2015)
A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
Ali Ghaleiha et al.
PSYCHIATRY RESEARCH (2015)
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6
I. Tsilioni et al.
TRANSLATIONAL PSYCHIATRY (2015)
Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
A. Masi et al.
MOLECULAR PSYCHIATRY (2015)
Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems
Urs Meyer
BIOLOGICAL PSYCHIATRY (2014)
Corticosteroid therapy in regressive autism: Preliminary findings from a retrospective study
Sailaja Golla et al.
BMC MEDICINE (2014)
Corticosteroid therapy in regressive autism: a retrospective study of effects on the Frequency Modulated Auditory Evoked Response (FMAER), language, and behavior
Frank H. Duffy et al.
BMC NEUROLOGY (2014)
N-Acetylcysteine as Treatment for Self-Injurious Behavior in a Child with Autism
Sarah Marler et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2014)
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial
Ali Ghaleiha et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2014)
Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum
Catherine Edmonson et al.
MOLECULAR AUTISM (2014)
A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders
Ahmad Ghanizadeh et al.
BMC PSYCHIATRY (2013)
Minocycline: far beyond an antibiotic
N. Garrido-Mesa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism: A 10-Week Randomized Study
Mohammad-Reza Mohammadi et al.
CLINICAL NEUROPHARMACOLOGY (2013)
An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders
Anilia Taliou et al.
CLINICAL THERAPEUTICS (2013)
Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
Ali Ghaleiha et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Microglial SK3 and SK4 Currents and Activation State are Modulated by the Neuroprotective Drug, Riluzole
B. -S. Liu et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
The link between some alleles on human leukocyte antigen system and autism in children
Gehan A. Mostafa et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
Mahtab Asadabadi et al.
PSYCHOPHARMACOLOGY (2013)
Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
Ali Ghaleiha et al.
PEDIATRIC DRUGS (2013)
Microglial Activation in Young Adults With Autism Spectrum Disorder
Katsuaki Suzuki et al.
JAMA PSYCHIATRY (2013)
A pilot open-label trial of minocycline in patients with autism and regressive features
Carlos A. Pardo et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2013)
A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism
Antonio Y. Hardan et al.
BIOLOGICAL PSYCHIATRY (2012)
Immune system gene dysregulation in autism and schizophrenia
Maximilian Michel et al.
DEVELOPMENTAL NEUROBIOLOGY (2012)
A CASE SERIES OF A LUTEOLIN FORMULATION (NEUROPROTEK®) IN CHILDREN WITH AUTISM SPECTRUM DISORDERS
T. C. Theoharides et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
D. A. Rossignol et al.
MOLECULAR PSYCHIATRY (2012)
Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?
S. Kapur et al.
MOLECULAR PSYCHIATRY (2012)
Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury
Joseph T. Giacino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Autism After Infection, Febrile Episodes, and Antibiotic Use During Pregnancy: An Exploratory Study
Hjordis Osk Atladottir et al.
PEDIATRICS (2012)
Association of HLA-DRB1 alleles and neuropsychological function in autism
Yi-Ling Chien et al.
PSYCHIATRIC GENETICS (2012)
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
Paul Ashwood et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
Amantadine protects dopamine neurons by a dual action: Reducing activation of microglia and inducing expression of GNDF in astroglia
Bernardino Ossola et al.
NEUROPHARMACOLOGY (2011)
Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders
Katsuaki Suzuki et al.
PLOS ONE (2011)
Maternal infection and immune involvement in autism
Paul H. Patterson
TRENDS IN MOLECULAR MEDICINE (2011)
Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism
John T. Morgan et al.
BIOLOGICAL PSYCHIATRY (2010)
Session 1: Antioxidants and the immune system Flavonoids as anti-inflammatory agents
Mauro Serafini et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism
Shahin Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder
Vala Rezaei et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway
Valentin A. Pavlov et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Neurometabolic disorders and dysfunction in autism spectrum disorders
Nassim Zecavati et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
Corticosteroid treatment of behaviour, language and motor regression in childhood disintegrative disorder
Santosh R. Mordekar et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2009)
Elevated immune response in the brain of autistic patients
Xiaohong Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
Hung-Ming Wu et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
Hjordis O. Atladottir et al.
PEDIATRICS (2009)
Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood
Marta Kubera et al.
PHARMACOLOGICAL REPORTS (2009)
Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation
Morag J. Young
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2008)
The peroxisome proliferator-activated receptor-γ agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-α- dependent manner in vitro and in vivo in mice
Gabriela Orasanu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children
Michael G. Chez et al.
PEDIATRIC NEUROLOGY (2007)
Effect of pioglitazone treatment on behavioral symptoms in autistic children
Marvin Boris et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders
James Jeffrey Bradstreet et al.
MEDICAL HYPOTHESES (2007)
A prospective, open-label trial of galantamine in autistic disorder
Rob Nicolson et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression:: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
N Müller et al.
MOLECULAR PSYCHIATRY (2006)
Cerebrospinal fluid and serum markers of inflammation in autism
AW Zimmerman et al.
PEDIATRIC NEUROLOGY (2005)
Corticosteroids for the treatment of Landau-Kleffner syndrome and continuous spike-wave discharge during sleep
DB Sinclair et al.
PEDIATRIC NEUROLOGY (2005)
Efficacy of lenalidomide in myelodysplastic syndromes
A List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-α and interferon-γ, and has potential in the treatment of arthritis
K Bendtzen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Immunoglobulins as an alternative strategy of psychopharmacological treatment of children with autistic disorder
H Niiederhofer et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Galantamine in the treatment of adult autism: A report of three clinical cases
M Hertzman
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2003)
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
N Müller et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder
BH King et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome
S Shenoy et al.
JOURNAL OF PEDIATRICS (2000)
Share Paper
